BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32387044)

  • 1. Venous Thromboembolism During Chemotherapy for Testicular Cancer: A Population-Based Study.
    Robinson AG; Wei X; Karim S; Raphael MJ; Bedard PL; Booth CM
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e188-e193. PubMed ID: 32387044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
    Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
    Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
    Fankhauser CD; Tran B; Pedregal M; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Del Muro XG; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL; Sweeney CJ; Connors JM
    Eur Urol Focus; 2021 Sep; 7(5):1130-1136. PubMed ID: 33032968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
    Terbuch A; Walser G; Stotz M; Gerger A; Posch F; Bauernhofer T
    Clin Genitourin Cancer; 2023 Feb; 21(1):24-31. PubMed ID: 36400695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy.
    Bamias A; Tzannis K; Dimitriadis I; Tsironis G; Papatheorodidi AM; Tsiara A; Fragkoulis C; Xirokosta A; Barbarousi D; Papadopoulos G; Zakopoulou R; Varkarakis I; Mitsogiannis I; Adamakis I; Alamanis C; Stravodimos K; Papatsoris AG; Dellis AE; Drivalos A; Ntoumas K; Matsouka H; Halvatsiotis P; Raptis A; Gerotziafas GT; Dimopoulos MA
    Clin Genitourin Cancer; 2020 Aug; 18(4):e457-e472. PubMed ID: 32007440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population-based study.
    Doiron RC; Booth CM; Wei X; Siemens DR
    BJU Int; 2016 Nov; 118(5):714-722. PubMed ID: 26950039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
    Karim S; Wei X; Leveridge MJ; Siemens DR; Robinson AG; Bedard PL; Booth CM
    Urol Oncol; 2019 Mar; 37(3):183.e17-183.e24. PubMed ID: 30478011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
    Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
    BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study.
    Abdel-Razeq H; Tamimi F; Abdel-Razeq R; Salah S; Omari Z; Salama O; Abufara A; Al-Tell A; Qahoush H; Nasman A; Taqash A; Alhalaseh Y; Bater R
    Clin Appl Thromb Hemost; 2021; 27():10760296211024756. PubMed ID: 34121471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
    Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
    J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study.
    Haugnes HS; Negaard HF; Jensvoll H; Wilsgaard T; Tandstad T; Solberg A
    Eur Urol Open Sci; 2021 Oct; 32():19-27. PubMed ID: 34667955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England.
    Bouras G; Burns EM; Howell AM; Bottle A; Athanasiou T; Darzi A
    PLoS One; 2015; 10(12):e0145759. PubMed ID: 26713434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity Among Survivors of Testicular Cancer: A Population-based Study.
    Raphael MJ; Wei X; Karim S; Robinson AG; Bedard PL; Booth CM
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):653-658. PubMed ID: 31056287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
    Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
    Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.
    Huang H; Korn JR; Mallick R; Friedman M; Nichols C; Menzin J
    J Thromb Thrombolysis; 2012 Nov; 34(4):446-56. PubMed ID: 22581282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.
    Kang MJ; Ryoo BY; Ryu MH; Koo DH; Chang HM; Lee JL; Kim TW; Kang YK
    Eur J Cancer; 2012 Mar; 48(4):492-500. PubMed ID: 22169121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in management and outcomes of testicular cancer: A population-based study.
    Leveridge MJ; Siemens DR; Brennan K; Izard JP; Karim S; An H; Mackillop WJ; Booth CM
    Cancer; 2018 Jul; 124(13):2724-2732. PubMed ID: 29660851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.